AII
ABMD

AGF Investments Inc’s Abiomed Inc ABMD Stock Holding History

AGF Investments Inc’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-732
Closed -$263K – 745
2021
Q4 		$263K Buy
+732
New +$247K ﹤0.01% 643
2021
Q2 		– Sell
-817
Closed -$260K – 837
2021
Q1 		$260K Sell
817
-20
-2% -$6.4K ﹤0.01% 560
2020
Q4 		$271K Sell
837
-75
-8% -$20.7K ﹤0.01% 527
2020
Q3 		$253K Buy
+912
New +$263K ﹤0.01% 603
2019
Q2 		– Sell
-103,793
Closed -$29.6M – 384
2019
Q1 		$29.6M Sell
103,793
-3,620
-3% -$1.2M 0.33% 94
2018
Q4 		$34.9M Buy
+107,413
New +$37.3M 0.42% 83

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AGF Investments Inc's ABMD Position: Q1 2022 in Review

AGF Investments Inc sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 732 shares — an estimated $263K sold.

AGF Investments Inc first reported a position in ABMD in Q4 2018 and held it in 6 quarters. The position peaked at $34.9M in Q4 2018. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • AGF Investments Inc reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 732 Abiomed Inc shares in Q1 2022, an estimated $263K.
  • AGF Investments Inc first reported a position in Abiomed Inc in Q4 2018 and held it in 6 quarters.
  • AGF Investments Inc's Abiomed Inc position peaked at $34.9M in Q4 2018.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.